Editor's Note Research shows antibiotic-resistant infections could lead to 8.2 million deaths annually by 2050, representing a 75% increase from current rates, according to a September 17 article in HealthDay. Published in the Lancet, the new study highlights the growing threat of growing threat of antimicrobial resistance (AMR), predicting that…

Read More

Editor's Note Nearly 20 years of data on the first 50 face transplants in the world indicate that survival rates exceed those of several solid organ transplants, according to a global study published September 18 in Jama Surgery. Conducted between 2005 and 2021, the study involved 18 transplant centers, assessed…

Read More

Editor's Note An analysis of two phase-III trials showed adjuvant administration of nivolumab (Opdivo) plus chemotherapy reduces the risk of recurrence or death in patients with resectable non-small cell lung cancer (NSCLC) by 40% compared to neoadjuvant nivolumab plus chemotherapy alone, Medpage Today reported September 9. "With the caveat that…

Read More

Editor's Note An American Hospital Association (AHA) analysis of data from Vizient reveals that hospital performance levels in the first quarter of this year was on par with performance prior to the COVID-19 pandemic, despite patients exhibiting more significant healthcare needs. Released this month, the report analyzes data from 2019…

Read More

Editor's Note B. Braun Medical Inc. has expanded last year’s recall of lnfusomat Space Infusion Pump systems to include more models. Designated by the US Food and Drug Administration (FDA) as Class 1—the most serious category indicating risk of severe injury or death—the recall was motivated by the risk of…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Fresenius Kabi’s recall of certain Ivenix infusion system components as Class 1, the most severe category indicating risk of serious injury or death. According to the agency’s September 16 announcement, the recalled items consist of a certain lot (3010538)…

Read More

Editor's Note In partnership with the World Health Organization (WHO), The Joint Commission and The Joint Commission and Joint Commission International (JCI) invite organizations, health professionals, patients, and their advocates to recognize World Patient Safety Day Tuesday, September 17. This year’s theme is “improving diagnosis for patient safety.” This theme…

Read More

Editor's Note A recent study conducted at a tertiary care hospital in India showed concurrent COVID-19 infection on patients undergoing emergency surgery resulted in notably longer hospital stays and higher rates of postoperative complications. Published September 8 in Cureus, the retrospective cohort study analyzed data from 48 COVID-19-positive patients and…

Read More

Editor's Note Joint Commission International (JCI) and the International Hospital Federation's Geneva Sustainability Centre (GSC) have introduced a new Healthcare Sustainability Certification (HSC) for healthcare organizations outside the U.S., according to a September 11 report from The Joint Commission. The goal of the new initiative is to address the nearly…

Read More

Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9.    The study, which analyzed 31,725 adults waitlisted for…

Read More